Earlier this year, the U.K. government announced £82.6 million ($102.2 million) in research funding for artificial intelligence (AI) companies engaged in developing solutions that accelerate…
Open-source adoption is modernising statistical workflows amidst a clinical trial environment mired in vast datasets, complex endpoints and increasing regulatory scrutiny. Sponsors are under pressure…
Whether for pathology or pharmaceutical purposes, laboratory space in the UK is in shortage – an issue not just for individual businesses but for the…
Forrester Consulting recently conducted a survey of European pharmaceutical companies commissioned by Hexagon, analysing their priorities and challenges in digital transformation. One of the most…
Monitoring in-country medical literature is an essential aspect of pharmacovigilance, providing an early pointer to adverse events in specific populations. Yet traditionally the process is…
Precision medicine is transforming healthcare by replacing the traditional one-size-fits-all approach with personalised care. By integrating a patient’s genetic profile, lifestyle factors, and environmental exposures,…
The biotechnology industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing, and real-time analytics reshaping drug discovery, personalised medicine, and healthcare…
MAIN5’s Michiel Stam analyses the findings of new research measuring the industry’s readiness for implementing the long-anticipated product data standards and for embracing FAIR data…
For pharmaceutical manufacturers, patents are vital stepping stones that allow companies to recover large investments and fuel future research and breakthroughs. They motivate manufacturers to…
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts….
